Comparison of Renal and Metabolic Effects of Empagliflozin and Dapagliflozin on Type 2 Diabetes-Induced Rats

被引：0
|
作者：
Herdan, Nadir Emre [1 ]
Gursu, Meltem [1 ]
Selek, Sahabettin [1 ]
Coban, Ganime [1 ]
Kazancioglu, Rumeyza [1 ]
机构：
[1] Bezmialem Vakif Univ, Tip Fak, Istanbul, Turkey
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO221
引用
收藏
页码：663 / 663
页数：1
相关论文
共 50 条
  • [31] Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse
    Hayden, Melvin R.
    Grant, DeAna G.
    Aroor, Annayya R.
    DeMarco, Vincent G.
    [J]. BRAIN SCIENCES, 2019, 9 (03)
  • [32] Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
    Johnston, Rhona
    Uthman, Olalekan
    Cummins, Ewen
    Clar, Christine
    Royle, Pamela
    Colquitt, Jill
    Tan, Bee Kang
    Clegg, Andrew
    Shantikumar, Saran
    Court, Rachel
    O'Hare, J. Paul
    McGrane, David
    Holt, Tim
    Waugh, Norman
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (02) : 1 - +
  • [33] Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes
    Iijima, Yasuhiro
    Nakayama, Masafumi
    Miwa, Takashi
    Yakou, Fumiyoshi
    Tomiyama, Hirofumi
    Shikuma, Junpei
    Ito, Rokuro
    Tanaka, Akihiko
    Manda, Naoki
    Odawara, Masato
    [J]. INTERNAL MEDICINE, 2023, 62 (05) : 681 - 688
  • [34] Beneficial metabolic effects of empagliflozin alone and empagliflozin on top of metformin treatment in type 1 diabetes patients
    Lunder, M.
    Janic, M.
    Sabovic, M.
    Janez, A.
    [J]. DIABETOLOGIA, 2019, 62 : S345 - S345
  • [35] COMPARISON OF CLINICAL OUTCOMES BETWEEN DAPAGLIFLOZIN VERSUS EMPAGLIFLOZIN IN PATIENTS WITH DIABETES MELLITUS
    Il Park, Jong
    Kim, Ung
    Park, Jong-Seon
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 677 - 677
  • [36] Resveratrol attenuates reproductive alterations in type 1 diabetes-induced rats
    Simas, Joana Nogueres
    Mendes, Talita Biude
    Paccola, Camila Cicconi
    Vendramini, Vanessa
    Miraglia, Sandra Maria
    [J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2017, 98 (06) : 312 - 328
  • [37] Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
    Ai-Yu Yang
    Hung-Chun Chen
    [J]. International Journal of Clinical Pharmacy, 2021, 43 : 1015 - 1023
  • [38] Comparison of the effects of empagliflozin and sitagliptin, as add-on to metformin, on serum levels of asprosin and metabolic parameters in patients with type 2 diabetes mellitus
    Talebi, Seyed Saman
    Rezaie, Shabnam
    Hajmiri, Minoo Sadat
    Zamanirafe, Maryam
    Ranjbar, Akram
    Moridi, Heresh
    Mirjalili, Mahtabalsadat
    Mehrpooya, Maryam
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [39] Dapagliflozin reduces renal threshold for glucose excretion in type 2 diabetes
    DeFronzo, R. A.
    Hompesch, M.
    Kasichayanula, S.
    Liu, X.
    Hong, Y.
    Pfister, M.
    Morrow, L. A.
    Leslie, B. R.
    Boulton, D. W.
    Ching, A.
    LaCreta, F. P.
    Griffen, S. C.
    [J]. DIABETOLOGIA, 2012, 55 : S306 - S306
  • [40] Dapagliflozin does not impact renal function in patients with type 2 diabetes
    Ptaszynska, A.
    Chalamandaris, A. -G.
    Sugg, J.
    Johnsson, K.
    Parikh, S.
    List, J. F.
    [J]. DIABETOLOGIA, 2012, 55 : S107 - S107
12345